OMX Nordic 40
2.523,26
PKT
-13,16
PKT
-0,52
%
Werbung
Analysen zu OMX Nordic 40-Werten
| Datum | Rating | Analyst | |
|---|---|---|---|
| 16.06.20 | Volvo (B) overweight | JP Morgan Chase & Co. | |
| 16.06.20 | Volvo (B) overweight | JP Morgan Chase & Co. | |
| 15.06.20 | ABB (Asea Brown Boveri) Underweight | JP Morgan Chase & Co. | |
| 15.06.20 | Hennes Mauritz (H M, H&M) Neutral | UBS AG | |
| 15.06.20 | Hennes Mauritz (H M, H&M) Underperform | Credit Suisse Group | |
| 15.06.20 | Hennes Mauritz (H M, H&M) Sell | Goldman Sachs Group Inc. | |
| 15.06.20 | Novo Nordisk overweight | JP Morgan Chase & Co. | |
| 12.06.20 | Novo Nordisk overweight | JP Morgan Chase & Co. | |
| 12.06.20 | Novo Nordisk Conviction Buy List | Goldman Sachs Group Inc. | |
| 11.06.20 | Novo Nordisk overweight | JP Morgan Chase & Co. | |
| 11.06.20 | ABB (Asea Brown Boveri) overweight | Barclays Capital | |
| 11.06.20 | ABB (Asea Brown Boveri) buy | UBS AG | |
| 10.06.20 | ABB (Asea Brown Boveri) Underweight | JP Morgan Chase & Co. | |
| 09.06.20 | Volvo (B) Conviction Buy | Goldman Sachs Group Inc. | |
| 09.06.20 | AstraZeneca buy | Kepler Cheuvreux | |
| 08.06.20 | AstraZeneca Outperform | Credit Suisse Group | |
| 08.06.20 | AstraZeneca Sell | UBS AG | |
| 08.06.20 | AstraZeneca Sell | Goldman Sachs Group Inc. | |
| 08.06.20 | AstraZeneca overweight | JP Morgan Chase & Co. | |
| 05.06.20 | Novo Nordisk Conviction Buy List | Goldman Sachs Group Inc. | |
| 05.06.20 | Novo Nordisk overweight | JP Morgan Chase & Co. | |
| 05.06.20 | Hennes Mauritz (H M, H&M) Neutral | UBS AG | |
| 05.06.20 | Novo Nordisk Neutral | UBS AG | |
| 05.06.20 | ABB (Asea Brown Boveri) Hold | Deutsche Bank AG | |
| 04.06.20 | AstraZeneca Sell | UBS AG | |
| 02.06.20 | AstraZeneca overweight | JP Morgan Chase & Co. | |
| 01.06.20 | AstraZeneca overweight | JP Morgan Chase & Co. | |
| 01.06.20 | A.P. Moeller - Maersk A-S (B) overweight | JP Morgan Chase & Co. | |
| 01.06.20 | Nokia overweight | JP Morgan Chase & Co. | |
| 29.05.20 | A.P. Moeller - Maersk A-S (B) Underweight | Barclays Capital | |
| 29.05.20 | AstraZeneca overweight | JP Morgan Chase & Co. | |
| 29.05.20 | AstraZeneca Sell | Goldman Sachs Group Inc. | |
| 28.05.20 | A.P. Moeller - Maersk A-S (B) Sell | Joh. Berenberg, Gossler & Co. KG (Berenberg Bank) | |
| 27.05.20 | AstraZeneca Sell | UBS AG | |
| 26.05.20 | A.P. Moeller - Maersk A-S (B) Hold | Jefferies & Company Inc. | |
| 25.05.20 | AstraZeneca Sell | UBS AG | |
| 22.05.20 | ABB (Asea Brown Boveri) buy | UBS AG | |
| 22.05.20 | AstraZeneca Sell | UBS AG | |
| 21.05.20 | Novo Nordisk Conviction Buy List | Goldman Sachs Group Inc. | |
| 20.05.20 | AstraZeneca overweight | Barclays Capital |